470 related articles for article (PubMed ID: 17569889)
21. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
Serre K; Giraudo L; Siret C; Leserman L; Machy P
Eur J Immunol; 2006 Jun; 36(6):1386-97. PubMed ID: 16673447
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
[TBL] [Abstract][Full Text] [Related]
23. Quantitative PCR for detection of the OT-1 transgene.
Wright KO; Murray DA; Crispe NI; Pierce RH
BMC Immunol; 2005 Aug; 6():20. PubMed ID: 16120215
[TBL] [Abstract][Full Text] [Related]
24. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide.
Heeg K; Kuon W; Wagner H
Eur J Immunol; 1991 Jun; 21(6):1523-7. PubMed ID: 1904363
[TBL] [Abstract][Full Text] [Related]
25. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H
Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141
[TBL] [Abstract][Full Text] [Related]
26. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
[TBL] [Abstract][Full Text] [Related]
27. Neutrophils sustain pathogenic CD8+ T cell responses in the heart.
Grabie N; Hsieh DT; Buono C; Westrich JR; Allen JA; Pang H; Stavrakis G; Lichtman AH
Am J Pathol; 2003 Dec; 163(6):2413-20. PubMed ID: 14633613
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic T-cell response following mouse liver transplantation is independent of the initial site of T-cell priming.
Klein I; Gassel HJ; Crispe IN
Transplant Proc; 2006 Dec; 38(10):3241-3. PubMed ID: 17175235
[TBL] [Abstract][Full Text] [Related]
29. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
30. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
[TBL] [Abstract][Full Text] [Related]
31. Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.
Gaffal E; Schweichel D; Tormo D; Steitz J; Lenz J; Basner-Tschakarjan E; Limmer A; Tüting T
Eur J Cell Biol; 2007 Dec; 86(11-12):817-26. PubMed ID: 16928407
[TBL] [Abstract][Full Text] [Related]
32. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
Wakita D; Chamoto K; Zhang Y; Narita Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
Int Immunol; 2006 Mar; 18(3):425-34. PubMed ID: 16415100
[TBL] [Abstract][Full Text] [Related]
33. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer.
Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abulsamad K; Adams SL
Clin Immunol; 2008 Aug; 128(2):205-18. PubMed ID: 18511346
[TBL] [Abstract][Full Text] [Related]
34. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M
Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051
[TBL] [Abstract][Full Text] [Related]
35. CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin.
Hegel JK; Knieke K; Kolar P; Reiner SL; Brunner-Weinzierl MC
Eur J Immunol; 2009 Mar; 39(3):883-93. PubMed ID: 19224637
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division.
Oehen S; Brduscha-Riem K
J Immunol; 1998 Nov; 161(10):5338-46. PubMed ID: 9820507
[TBL] [Abstract][Full Text] [Related]
37. CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection.
Graefe SE; Jacobs T; Wächter U; Bröker BM; Fleischer B
Parasite Immunol; 2004 Jan; 26(1):19-28. PubMed ID: 15198642
[TBL] [Abstract][Full Text] [Related]
38. CD8+ cytotoxic T cells induce relapsing colitis in normal mice.
Nancey S; Holvöet S; Graber I; Joubert G; Philippe D; Martin S; Nicolas JF; Desreumaux P; Flourié B; Kaiserlian D
Gastroenterology; 2006 Aug; 131(2):485-96. PubMed ID: 16890603
[TBL] [Abstract][Full Text] [Related]
39. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
Ma H; Kapp JA
Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
[TBL] [Abstract][Full Text] [Related]
40. The cytotoxic T lymphocyte response against a protein antigen does not decrease the antibody response to that antigen although antigen-pulsed B cells can be targets.
Wang W; Golding B
Immunol Lett; 2005 Sep; 100(2):195-201. PubMed ID: 15916814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
